Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

Phase I/II combination umbrella trial in progressive/relapsed/refractory pediatric low-grade glioma (pLGG) (EPILOGUE) Pending

2024-516896-34-00 progressive/relapsed/refractory pediatric low-grade gli 9
Prognostic value of early assessment by ⁶⁸Ga-DOTATATE PET/CT for the treatment of well-differentiated grade 2 gastroenteropancreatic neuroen… Pending

2025-524942-87-00 Gastroenteropancreatic neuroendocrine tumors 6
Tandem therapy LutaPol/ltraPol ( I 77Lu / 90Y-DOTATATE) as an effective method in the treatment of neuroendocrine neoplasmas. Pending

2024-516503-17-01 Diagnosed and histopathologically confirmed diffuse or 5
Phase 2 randomised study of Radspherin® in patients with peritoneal carcinomatosis from colorectal carcinoma after cytoreductive surgery (CR… Pending

2023-508496-37-00 Carcinomatosis of peritoneal cavity 4
PNOC029_Tovorafenib for the treatment of newly diagnosed or recurrent craniopharyngioma in children and young adults Pending

2024-511510-20-00 craniopharyngioma 4
Electrochemotherapy with Carboplatinum plus Bleomycin versus Bleomycin alone in vulvar cancer: the ElechtraPlatinum Study. A Randomized Cont… Pending

2024-518370-14-00 relapsing vulvar carcinoma already subjected to multipl 4
A study in people with advanced extrapulmonary neuroendocrine cancer to compare obrixtamig plus carboplatin and etoposide treatment with sta… Pending

2025-523869-22-00 advanced or metastatic extrapulmonary neuroendocrine ca 5
Neoadjuvant nivolumab and ipilimumab for patients with high-risk uveal melanoma Pending

2025-524953-15-00 Uveal melanoma 3
A biomarker enrichment trial of anti-EGFR agents in patients with advanced colorectal cancer (aCRC) with wild-type RAS and right primary tum… Pending

2025-521209-42-00 advanced colorectal cancer with wild-type RAS and right 6
Avelumab Short Maintenance Trial Pending

2024-512975-11-01 urothelial cancer 11
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older with Locally Advanced or Metastatic… Pending

2024-518871-74-00 Locally Advanced or Metastatic Solid Tumours that harbo 4
A clinical trial studying the effect of Tirzepatide in women living with endometrial cancer Pending

2025-523877-40-00 Endometrial adenocarcinoma 4
A study aimed at Optimise and Personalise Immunological Therapy of relapsed chronic lymphocytic leukaemia patients (OPTIC) Pending

2024-513917-11-01 Adult patients with chronic lymphocytic leukemia/small 9
VINORELBINE INHIBITS ONCOGENIC FUNCTIONS OF MKK3: A NEW THERAPEUTIC OPPORTUNITY FOR PATIENTS WITH METASTATIC COLORECTAL CANCER Pending

2024-519459-27-00 METASTATIC COLORECTAL CANCER 4
Remimazolam versus propofol for deep sedation during Endoscopic Ultrasound (EUS) procedures. A randomized controlled trial. Pending

2025-521784-12-00 Gastric and pancreatic cancer 6
Phase II study of Durvalumab (MEDI4736) plus Total Neoadjuvant Therapy (TNT) in locally advanced rectal cancer (The DUREC trial) Pending

2024-515240-24-00 Locally advanced rectal cancer 4
Randomized, Open-Label, Phase 3 Clinical Trial of N-803 Plus Tislelizumab and Docetaxel Versus Docetaxel Monotherapy in Participants With Ad… Pending

2025-521221-32-00 Advanced or Metastatic Non-Small Cell Lung Cancer 5
Phase II single arm study with CABozantinib in Non-Small Cell Lung Cancer patients with MET deregulation Pending

2024-518386-95-02 Non small-cell lung cancer 4
A Phase 2/3 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Participants with Stage 4 Non-Small Cell Lung Cancer. Pending

2025-525013-23-00 Stage 4 (IV) Non-Small Cell Lung Cancer (NSCLC) 4
Study of the effect and tolerability of INT230-6 by direct injection into the tumor, followed by neoadjuvant treatment with chemoimmunothera… Pending

2024-512511-49-00 Early triple-negative breast cancer (TNBC) 4
Ultra-hypofractionated radiotHErapy and concomitant oral RelugOlix for treatment of intermediate risk prostate cancer. (Ultra-HERO trial) Pending

2024-518388-37-00 Intermediate risk prostate cancer 4
Test-Retest Evaluation of [18F]F-AraG in Lung Tumors (TREAT) Pending

2025-522404-24-01 Lung Cancer 10
A Clinical Trial Evaluating the Efficacy of Valganciclovir in Glioblastoma Patients Pending

2023-504846-73-01 Glioblstoma WHO grade IV 4
DALY II USA/MB-CART2019.1 for DLBCL Pending

2023-508508-39-01 Relapsed/refractory diffuse large B cell lymphoma (R-R 4